Special Programme on Human Reproduction
http://dbpedia.org/resource/Special_Programme_on_Human_Reproduction
The Special Programme on Human Reproduction (HRP), also known as the Special Programme of Research, Development and Research Training in Human Reproduction, was a World Health Organization (WHO) endeavor. It resulted in the following marketed combined injectable contraceptives:
* Estradiol cypionate/medroxyprogesterone acetate (EC/MPA; brand names Cyclofem, Lunelle; code names HRP-112, Cyclo-Provera)
* Estradiol valerate/norethisterone enanthate (EV/NETE; brand name Mesigyna; code name HRP-102) And in the following never-marketed progestogen injectable contraceptives:
rdf:langString
rdf:langString
Special Programme on Human Reproduction
xsd:integer
58508899
xsd:integer
1062046813
rdf:langString
The Special Programme on Human Reproduction (HRP), also known as the Special Programme of Research, Development and Research Training in Human Reproduction, was a World Health Organization (WHO) endeavor. It resulted in the following marketed combined injectable contraceptives:
* Estradiol cypionate/medroxyprogesterone acetate (EC/MPA; brand names Cyclofem, Lunelle; code names HRP-112, Cyclo-Provera)
* Estradiol valerate/norethisterone enanthate (EV/NETE; brand name Mesigyna; code name HRP-102) And in the following never-marketed progestogen injectable contraceptives:
* Levonorgestrel butanoate (LNG-B; code name HRP-002)
* Levonorgestrel cyclobutylcarboxylate (code name HRP-001)
* Levonorgestrel cyclopropylcarboxylate (code name HRP-003)
xsd:nonNegativeInteger
4093